My sense is that there is a lot of impact to be made from just convincing US foundations to donate to charities abroad, which is probably more tractable than selling EA as an entire concept, and is still very compatible with TBP.
(In my opinion they are basically correct about TBP and EA being incompatible!)
This is great, thank you for doing this hard work!
A couple of disagreements:
“I think it’s important for many to realise the importance of other players and funding sources in the landscape. This could mean many more funding opportunities EAs are systematically neglecting.”
My view is that many players and funding sources means that fewer important funding opportunities will be missed.
“I was struck by how little philanthropy has been directed towards tech development for biosecurity, mitigating GCBRs, and policy advocacy for a range of topics from regulating dual-use research of concern (DURC) to mitigating risks from bioweapons.”
I 100% agree regarding policy advocacy, but I disagree regarding tech development and mitigating GCBRs for reasons you do mention—that many different interventions, including vaccine R&D and broad public health systems strengthening in LMICs, contribute to mitigating GCBRs.